You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fenretinide

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Neuroblastoma, Neuroblastoma Trial in Oklahoma City, Dallas, Fort Worth (Fenretinide Lym-X-Sorb Oral Powder,

No longer available
  • Recurrent Neuroblastoma
  • Neuroblastoma
  • Oklahoma City, Oklahoma
  • +2 more
Mar 17, 2022

Long COVID Trial (LAU-7b for 3 cycles, LAU-7b for 1 cycle, then , Placebo for 3 cycles)

Not yet recruiting
  • Long COVID
  • LAU-7b for 3 cycles
  • +2 more
  • (no location specified)
Aug 16, 2023

Solid Tumor Trial in Dallas, Lubbock (Fenretinide (4-HPR) plus Intravenous Safingol)

Terminated
  • Solid Tumor
  • Fenretinide (4-HPR) plus Intravenous Safingol
  • Dallas, Texas
  • +2 more
Mar 17, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Fenretinide
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Fenretinide
  • Chicago, Illinois
    Rush University Medical Center
Oct 24, 2022

Obesity, Insulin Resistance Trial in San Diego (Fenretinide, Placebo)

Suspended
Has Results
  • Obesity
  • Insulin Resistance
  • Fenretinide
  • Placebo
  • San Diego, California
    University of California at San Diego Hospitals
Jan 22, 2021

Ovarian Cancer, Cancer of Ovary, Cancer of the Ovary Trial in Oklahoma City, Dallas, Lubbock (Fenretinide/LXS + Ketoconazole)

Terminated
  • Ovarian Cancer
  • +4 more
  • Fenretinide/LXS + Ketoconazole
  • Oklahoma City, Oklahoma
  • +2 more
Aug 25, 2020

COVID-19 Disease Trial in Canada, United States (LAU-7b, Placebo oral capsule)

Recruiting
  • COVID-19 Disease
  • Chandler, Arizona
  • +28 more
Aug 19, 2022

Peripheral T-cell Lymphoma Trial in United States (Fenretinide)

Unknown status
  • Peripheral T-cell Lymphoma
  • Fenretinide
  • Gilbert, Arizona
  • +10 more
Jul 22, 2019

Cystic Fibrosis Trial in Australia, Canada, United States (LAU-7b, Placebo oral capsule)

Completed
  • Cystic Fibrosis
  • Long Beach, California
  • +39 more
Oct 3, 2021

Melanoma (Skin) Trial in Philadelphia (fenretinide, tretinoin)

Completed
  • Melanoma (Skin)
  • Philadelphia, Pennsylvania
    University of Pennsylvania Cancer Center
Dec 30, 2018

High-Risk Cancer Trial in Milan (Fenretinide, Placebo)

Terminated
  • High-Risk Cancer
  • Fenretinide
  • Placebo
  • Milan, Italy
    European Institute of Oncology
Nov 6, 2018

Bladder Cancer Trial in Houston, Seattle (Fenretinide, Placebo)

Completed
  • Bladder Cancer
  • Fenretinide
  • Placebo
  • Houston, Texas
  • +2 more
Nov 7, 2018

Head Neck Cancer Trial in Houston (Fenretinide)

Completed
  • Head and Neck Cancer
  • Fenretinide
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Oct 30, 2018

Cervical Cancer, Precancerous Condition Trial in Houston (Fenretinide, Placebo)

Completed
  • Cervical Cancer
  • Precancerous Condition
  • Fenretinide
  • Placebo
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Oct 23, 2018

Head Neck Cancer Trial in Houston (Fenretinide (4-HPR), SCH66336)

Terminated
  • Head and Neck Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 14, 2018

Brain and CNS Tumors Trial in United States (fenretinide)

Completed
  • Brain and Central Nervous System Tumors
  • fenretinide
  • Los Angeles, California
  • +10 more
Jun 25, 2018

Ewing's Sarcoma Trial in Essen, Muenster (Zoledronic acid, Busulfan, Treosulfan)

Completed
  • Ewing's Sarcoma
  • Zoledronic acid
  • +2 more
  • Essen, Germany
  • +1 more
Oct 18, 2019

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (fenretinide)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • fenretinide
  • Los Angeles, California
  • +3 more
Jul 18, 2017

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

Neuroblastoma Trial in Canada, United States (fenretinide, high performance liquid chromatography, pharmacological study)

Completed
  • Neuroblastoma
  • fenretinide
  • +2 more
  • Los Angeles, California
  • +12 more
Dec 20, 2016

Cystic Fibrosis Trial in Montreal (Fenretinide, Placebo)

Completed
  • Cystic Fibrosis
  • Fenretinide
  • Placebo
  • Montreal, Quebec, Canada
    Montreal Chest Institute
Jul 10, 2016

Neuroblastoma Trial in United States (fenretinide lipid matrix, ketoconazole, laboratory biomarker analysis)

Completed
  • Neuroblastoma
  • fenretinide lipid matrix
  • +3 more
  • Los Angeles, California
  • +10 more
Feb 11, 2016

Solid Tumor Trial in Detroit (fenretinide)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • fenretinide
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 9, 2014

Squamous Cell Carcinoma of Mouth, Intraepithelial Neoplasia Trial in Louisville, Chapel Hill, Columbus (10% FBR containing

Completed
Has Results
  • Squamous Cell Carcinoma of Mouth
  • Intraepithelial Neoplasia
  • 10% FBR containing bioadhesive gel
  • placebo gel
  • Louisville, Kentucky
  • +2 more
Aug 12, 2015